Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 351 - 400 out of 16,206

Document Document Title
WO/2022/082148A1
Processes and systems for producing isomeric mixtures of aromatic amine monomers from aromatic feeds. An example process for producing isomeric mixtures of aromatic amine monomers from aromatic feeds may include nitrating at least a port...  
WO/2022/080715A1
The present invention provides a novel compound and an organic light-emitting device comprising same.  
WO/2022/076383A1
The invention provides novel sulfonanilide and benzylsulfonyl derivatives, and compositions and methods of preparation and use thereof, that are useful in treating various diseases and disorders related to TRPML activities such as lysoso...  
WO/2022/075746A1
The present invention provides: a novel compound capable of improving the light-emitting efficiency, stability, and lifespan of an element; an organic electrical element using same; and an electronic device thereof.  
WO/2022/068292A1
The present application relates to an organic compound, and an electronic element and an electronic device using same. The structural formula of the organic compound is shown as formula 1. According to the organic compound provided in th...  
WO/2022/068499A1
The present invention belongs to the technical field of liquid crystal materials, and specifically relates to a thiophene-containing liquid crystal compound, a preparation method therefor and the use thereof. The thiophene-containing liq...  
WO/2022/065730A1
Provided is a cyano group-substituted aryl or heteroaryl derivative which effectively absorbs high-energy light in the UV region from an external light source to minimize damage to organic materials inside an organic electroluminescent d...  
WO/2022/066774A1
This disclosure provides pharmaceutical compounds to treat medical disorders, such as complement-mediated disorders, including complement C1-mediated disorders.  
WO/2022/065745A1
The present specification relates to a compound represented by chemical formula 1 and an organic light-emitting device including same.  
WO/2022/052047A1
Provided are a microbicide and a sterilization method, wherein the microbicide contains a compound represented by chemical formula (I), wherein Ar1 and Ar2 are each independently a substituent-substituted or unsubstituted phenyl, naphthy...  
WO/2022/048679A1
Disclosed are a thiophene structure-containing oxime ester photoinitiator, a preparation method therefor, and a photosensitive resin composition containing the photoinitiator and capable of serving as an alkaline photographic developer. ...  
WO/2022/048922A1
The present invention relates to a compound of the following formula (I) or (II), optionally in the form of a pharmaceutically acceptable salt, solvate, polymorph, cocrystal, tautomer, racemate, enantiomer, or diastereomer or mixture the...  
WO/2022/051565A1
The invention provides substituted 4-piperidinyl-quinazolines, 4-piperidinyl-pyrimidine-2-amines, and related compounds, pharmaceutical compositions, their use for inhibiting ERK5 activity, and their use in the treatment of medical disor...  
WO/2022/045231A1
This ester compound is represented by formula (1) [wherein R1 to R24 are each independently a hydrogen atom, a halogen atom, a hydrocarbon group, or a heteroatom-containing hydrocarbon group; R1 to R10, R23, and R24 may be bonded to each...  
WO/2022/047148A1
Biologically silent small molecules that bind to RNA motifs but do not modify or negate the bioactivity of the RNA motif can be conjugated with an RNAase activator thereby degrading the RNA motif and negating its bioactivity.  
WO/2022/043322A1
The present invention relates to compounds of formula (la) and the use thereof as inhibitors of P. aeruginosa virulence factor LasB. Formula (la). These compounds are useful in the treatment of bacterial infections, especially caused by ...  
WO/2022/040747A1
The present invention relates to compounds that have zinc and/or iron ionophore activity and their use in treating diseases that are modulated by reducing zinc and/or iron. In particular embodiments, the compounds are compounds of formul...  
WO/2020/249956A9
Compounds of general formula (I), which are useful for treating respiratory disease and other diseases and conditions modulated by TMEM16A. wherein A is defined as Formula.  
WO/2022/045618A1
Provided is a tertiary amine derivative, which effectively absorbs high-energy external light source in a UV region to minimize damage to organic materials inside an organic electroluminescent device, and thus contributes to a substantia...  
WO/2022/039520A1
The present invention provides a novel compound and an organic light-emitting device using same.  
WO/2022/039340A1
The present specification relates to a heterocyclic compound represented by chemical formula 1 and an organic light-emitting device comprising same.  
WO/2022/039563A1
The present application relates to a novel compound having inhibitory activity on prostaglandin E2 receptor and uses thereof, and provides a compound represented by formula I, a solvate, stereoisomer or pharmaceutically acceptable salt t...  
WO/2022/038066A1
The present invention relates to compounds which are suitable for use in electronic devices, and to electronic devices, in particular organic electroluminescent devices, containing these compounds.  
WO/2022/033280A1
The present invention relates to an organic electroluminescent device and an electronic apparatus. The organic electroluminescent device comprises an anode, a hole transport layer, an organic light-emitting layer, an electron transport l...  
WO/2022/032879A1
Provided is a photochemical synthesis method for a heteroaryl amine compound. The photochemical synthesis method comprises: step S1, mixing raw materials comprising a heteroaryl nitro compound, a solvent, and a photocatalyst to obtain a ...  
WO/2022/032179A1
Disclosed herein are, inter alia, compounds modulating activity and methods of use thereof for treating PIN1 -mediated disorders.  
WO/2022/028429A1
The present invention relates to use of a novel Arf1 inhibitor; a method for treating refractory, recurrent or metastatic cancer using these compounds; an investigate method for selectively killing cancer stem cells and cancer cells usin...  
WO/2022/024928A1
The present invention addresses the problem of providing an actinic-ray-sensitive or radiation-sensitive resin composition capable of forming patterns having excellent LWR performance. Also provided are a resist film, a pattern formation...  
WO/2022/025071A1
Provided is a compound represented by general formula (1). (In general formula (1), Ar1 and Ar2 independently represent groups selected from (AA), R1 to R6 represent hydrogen atoms, hydrocarbon groups, or heteroatom-containing hydrocarbo...  
WO/2022/023929A1
Disclosed is a process for the production of erdosteine or the analogues and derivatives thereof which comprises reacting a solution of an activated derivative of thiodiglycolic acid with a solution of homocysteine thiol actone or a salt...  
WO/2022/017975A1
Compounds of the formula (I) wherein the substituents are as defined in claim 1. Furthermore, the present invention relates to agrochemical compositions which comprise compounds of formula (I), to preparation of these compositions, and t...  
WO/2022/020714A1
Described herein are HSD17B13 inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of liver disease, metabolic disease, or cardiovascular disease, such...  
WO/2022/017531A1
The present invention relates to a compound for treating thrombotic diseases. Specifically, the present invention provides a compound represented by formula I, or a pharmaceutically acceptable salt, or an enantiomer, or a diastereoisomer...  
WO/2022/016898A1
The present application provides an organic compound, an organic electroluminescence device and an electronic apparatus. The chemical structure of the organic compound in the present application comprises an adamantane spirofluorene ring...  
WO/2022/017997A1
The present invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices, and to electronic devices which comprise these compounds.  
WO/2022/013417A1
Compounds of the formula (I), wherein the substituents are as defined in claim 1. Furthermore, the present invention relates to agrochemical compositions which comprise compounds of formula (I), to preparation of these compositions, and ...  
WO/2022/013378A1
The present invention relates to compounds of general formula (I) inhibiting lysophosphatidic acid receptor 1 (LPA1), particularly the invention relates to compounds that are Ami do cyclohexane acid derivatives, methods of preparing such...  
WO/2022/007909A1
The present application relates to the technical field of organic material and provides a nitrogen-containing compound, an electronic component and an electronic device. The nitrogen-containing compound has a structure as shown in formul...  
WO/2022/010537A1
Provided herein are small molecules that bind to GAS41 and inhibit GAS41 activity, and methods of use thereof for the treatment of cancer.  
WO/2022/002077A1
Disclosed in the present invention are an aryl aromatic heterocyclic derivative and preparation thereof and use thereof. The structure is as shown in formula I, and in this formula, the definitions of substituents are as stated in the de...  
WO/2022/004473A1
The present invention provides: a photoelectric conversion element which has excellent photoelectric conversion efficiency with respect to blue to green light (specifically, light having a wavelength of from 400 nm to 550 nm), and which ...  
WO/2021/261447A1
The present invention addresses a first problem of providing a photoelectric conversion element having high external quantum efficiency and little response variation. The present invention also addresses a second problem of providing an ...  
WO/2021/259798A1
The present invention relates to a chemical compound having the general formula (I): wherein R1 is a phenyl group or a substituted phenyl group, R2 is a meta-substituted phenyl group and RTA is a substituted or unsubstituted thiophene ri...  
WO/2021/249337A1
Disclosed in the present invention is a series of dimethylsulfoximine derivatives, and specifically disclosed are a compound represented by formula (II) and a pharmaceutically acceptable salt thereof.  
WO/2021/238622A1
Disclosed in the present invention are a compound and an application thereof. The compound of the present invention has the structure shown in formula (1). The compound obtained in the present invention by connecting phenanthrene and flu...  
WO/2021/241900A1
The present specification relates to a compound of chemical formula 1 and an organic light-emitting device comprising same.  
WO/2021/234551A1
A small crystal size, high surface area aluminogermanosilicate molecular sieve material, designated SSZ-120, is provided. SSZ-120 can be synthesized using 3,3'-[2,6-naphthalenebis(methylene)]bis[1,2-dimethyl-1H-imid azolium] dications as...  
WO/2021/230513A1
Provided is an organic compound contributing to improving the substantial light efficiency and field of view of an organic electroluminescent device. The organic electroluminescent device according to the present invention comprises: a f...  
WO/2021/230653A1
The present invention relates to: an anthracene derivative compound having a specific structure; and an organic light-emitting device having low-voltage driving characteristics, comprising same, and also relates to an organic light-emitt...  
WO/2021/227655A1
Provided are a compound, an organic electroluminescent device, and a display device. The compound has a structure as shown in formula I. The introduction of the substituent Ar2 at position 1 on a naphthalene ring can not only adjust the ...  

Matches 351 - 400 out of 16,206